ETFs

Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Average Rat...

Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have received ...

Zacks Research Has Bullish Estimate for ZION Q2 Earnings

Zions Bancorporation, National Association (NASDAQ:ZION – Free Report) – Researc...

Qorvo, Inc. (NASDAQ:QRVO) Given Consensus Recommendatio...

Qorvo, Inc. (NASDAQ:QRVO – Get Free Report) has received an average rating of “H...

Analysts Set Agnico Eagle Mines Limited (NYSE:AEM) Targ...

Shares of Agnico Eagle Mines Limited (NYSE:AEM – Get Free Report) (TSE:AEM) have...

Brokerages Set Verint Systems Inc. (NASDAQ:VRNT) Price ...

Shares of Verint Systems Inc. (NASDAQ:VRNT – Get Free Report) have been given a ...

Analyzing Mynd.ai (OTCMKTS:MYND) and Youdao (NYSE:DAO)

Mynd.ai (OTCMKTS:MYND – Get Free Report) and Youdao (NYSE:DAO – Get Free Report)...

IMAX Co. (NYSE:IMAX) Receives $30.56 Average Target Pri...

Shares of IMAX Co. (NYSE:IMAX – Get Free Report) have been assigned an average r...

Contrasting Nikola (NASDAQ:NKLA) and VinFast Auto (NASD...

VinFast Auto (NASDAQ:VFS – Get Free Report) and Nikola (NASDAQ:NKLA – Get Free R...

LFGY: Broader Means Better

Q2 EPS Estimates for Legend Biotech Lifted by William B...

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – William Blair boosted their Q2 ...

KeyCorp Issues Positive Forecast for Cadence Design Sys...

Cadence Design Systems (NASDAQ:CDNS – Get Free Report) had its target price hois...

Benitec Biopharma (NASDAQ:BNTC) Receives Market Outperf...

Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “market outper...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Downgraded by St...

StockNews.com downgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free ...

Axsome Therapeutics (NASDAQ:AXSM) Raised to Strong-Buy ...

Cantor Fitzgerald upgraded shares of Axsome Therapeutics (NASDAQ:AXSM – Free Rep...

Wells Fargo & Company Issues Pessimistic Forecast for C...

Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) had its price ta...

Canaan (NASDAQ:CAN) Receives “Buy” Rating from Rosenbla...

Canaan (NASDAQ:CAN – Get Free Report)‘s stock had its “buy” rating restated by e...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.